Total Payments
$6,012
2024 Payments
$1,166
Companies
29
Transactions
175
Medicare Patients
12,221
Medicare Billing
$9.7M
Payment Breakdown by Category
Food & Beverage$5,094 (84.7%)
Travel$900.00 (15.0%)
Education$17.84 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,094 | 172 | 84.7% |
| Travel and Lodging | $900.00 | 2 | 15.0% |
| Education | $17.84 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Hospital Products Inc. | $955.98 | 26 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $632.15 | 27 | $0 (2024) |
| Allergan, Inc. | $533.29 | 11 | $0 (2021) |
| Genentech USA, Inc. | $522.11 | 25 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $500.00 | 1 | $0 (2019) |
| Dutch Ophthalmic, USA | $406.22 | 2 | $0 (2018) |
| BIOTISSUE HOLDINGS INC. | $319.73 | 8 | $0 (2024) |
| Alcon Research Ltd | $301.64 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $181.35 | 9 | $0 (2024) |
| AbbVie Inc. | $171.00 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,166 | 44 | Regeneron Healthcare Solutions, Inc. ($195.05) |
| 2023 | $965.33 | 36 | Mallinckrodt Hospital Products Inc. ($207.18) |
| 2022 | $738.04 | 33 | Mallinckrodt Hospital Products Inc. ($185.55) |
| 2021 | $808.81 | 36 | Mallinckrodt Hospital Products Inc. ($356.02) |
| 2020 | $317.47 | 12 | Regeneron Healthcare Solutions, Inc. ($134.25) |
| 2019 | $817.53 | 7 | Regeneron Pharmaceuticals, Inc. ($500.00) |
| 2018 | $1,199 | 7 | Dutch Ophthalmic, USA ($406.22) |
All Payment Transactions
175 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/13/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/21/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $149.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/08/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Ophthalmology | ||||||
| 11/06/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: Ophthalmology | ||||||
| 11/05/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: Dry eyes | ||||||
| 11/05/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/23/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/15/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Ophthalmology | ||||||
| 10/04/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/28/2024 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Ophthalmology | ||||||
| 09/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/17/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Ophthalmology | ||||||
| 08/28/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/28/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/27/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: Ophthalmology | ||||||
| 08/22/2024 | Oyster Point Pharma, Inc. | RYZUMVI (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: Pharmacologically-induced mydriasis | ||||||
| 07/30/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: Ophthalmology | ||||||
| 07/16/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 07/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/25/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 4,054 | 28,539 | $6.9M | $3.1M |
| 2022 | 18 | 3,504 | 13,996 | $6.8M | $3.0M |
| 2021 | 14 | 3,143 | 9,883 | $5.8M | $2.7M |
| 2020 | 10 | 1,520 | 3,388 | $2.0M | $912,635 |
Total Patients
12,221
Total Services
55,806
Medicare Billing
$9.7M
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 247 | 2,654 | $3.3M | $1.8M | 55.4% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 39 | 17,640 | $740,880 | $513,454 | 69.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 290 | 1,578 | $1.4M | $176,942 | 12.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,113 | 1,479 | $295,800 | $158,292 | 53.5% |
| 92134 | Imaging of retina | Office | 2023 | 1,101 | 2,716 | $407,400 | $98,750 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 308 | 628 | $138,160 | $72,620 | 52.6% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 18 | 370 | $185,000 | $66,541 | 36.0% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 18 | 399 | $139,650 | $63,207 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 232 | 319 | $54,975 | $25,566 | 46.5% |
| 92250 | Photography of the retina | Office | 2023 | 511 | 540 | $73,340 | $17,961 | 24.5% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 11 | 11 | $35,200 | $11,716 | 33.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 60 | 60 | $14,400 | $7,572 | 52.6% |
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 12 | 15 | $37,500 | $7,037 | 18.8% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 42 | 42 | $14,700 | $5,473 | 37.2% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 18 | 21 | $42,000 | $4,633 | 11.0% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 13 | 35 | $3,500 | $1,975 | 56.4% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 21 | 32 | $11,900 | $1,494 | 12.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 244 | 2,915 | $3.6M | $2.1M | 57.6% |
| 67028 | Injection of drug into eye | Office | 2022 | 275 | 1,564 | $1.3M | $175,586 | 13.1% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 28 | 665 | $332,500 | $148,176 | 44.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 949 | 1,283 | $256,600 | $136,849 | 53.3% |
| 92134 | Imaging of retina | Office | 2022 | 1,059 | 2,747 | $412,050 | $100,903 | 24.5% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 17 | 2,880 | $120,960 | $85,943 | 71.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 311 | 658 | $144,760 | $75,704 | 52.3% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2022 | 16 | 413 | $144,550 | $65,174 | 45.1% |
About Dr. Christopher Adam, MD
Dr. Christopher Adam, MD is a Ophthalmology healthcare provider based in East Patchogue, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2014. The National Provider Identifier (NPI) number assigned to this provider is 1962821355.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Adam, MD has received a total of $6,012 in payments from pharmaceutical and medical device companies, with $1,166 received in 2024. These payments were reported across 175 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($5,094).
As a Medicare-enrolled provider, Adam has provided services to 12,221 Medicare beneficiaries, totaling 55,806 services with total Medicare billing of $9.7M. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location East Patchogue, NY
- Active Since 04/14/2014
- Last Updated 02/08/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1962821355
Products in Payments
- ACTHAR (Biological) $1,063
- OZURDEX (Drug) $704.29
- EVA Ophthalmic Surgical System (Device) $406.22
- EYLEA (Biological) $361.96
- Vabysmo (Drug) $307.32
- EYLEA HD (Biological) $270.19
- PROKERA (Device) $224.40
- YUTIQ (Drug) $165.02
- TEPEZZA (Drug) $151.48
- Izervay (Drug) $151.44
- AcrySof (Device) $142.37
- Lucentis (Biological) $117.89
- ILUVIEN (Drug) $107.35
- Syfovre (Drug) $97.51
- PURIFIED CORTROPHIN GEL (Drug) $69.15
- BEOVU (Drug) $67.22
- TYRVAYA (Drug) $57.28
- VABYSMO (Drug) $57.28
- Simbrinza (Drug) $50.42
- Flarex (Drug) $33.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.